These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11965297)

  • 41. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The long-awaited drop in prostate cancer mortality: what does it mean?
    Levy IG
    Cancer Prev Control; 1998 Aug; 2(4):159. PubMed ID: 10093626
    [No Abstract]   [Full Text] [Related]  

  • 43. PSA testing: press coverage in UK and US is an ocean apart.
    Cohen D
    BMJ; 2009 Mar; 338():b1287. PubMed ID: 19329514
    [No Abstract]   [Full Text] [Related]  

  • 44. Screening for prostate cancer: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 Mar; 103(3):107-10; discussion 111. PubMed ID: 12626949
    [No Abstract]   [Full Text] [Related]  

  • 45. [Prostatic cancer in Sweden 1998-2003. Drastic change of the disease panorama].
    Varenhorst E; Garmo H; Holmberg L; Stattin P; Johansson JE
    Lakartidningen; 2006 Feb 1-7; 103(5):285-8. PubMed ID: 16512566
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States.
    Cheng I; Yu MC; Koh WP; Pike MC; Kolonel LN; Henderson BE; Stram DO
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1692-6. PubMed ID: 16030103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostate cancer incidence and mortality in selected countries of Central Europe.
    Ondrusova M; Muzik J; Kliment J; Gulis G; Ondrus D
    Klin Onkol; 2011; 24(2):126-32. PubMed ID: 21638996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Descriptive epidemiology of prostate cancer in Japan and Western countries].
    Wakai K
    Nihon Rinsho; 2005 Feb; 63(2):207-12. PubMed ID: 15714967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate Testing for Cancer and Treatment (ProtecT) feasibility study.
    Donovan J; Hamdy F; Neal D; Peters T; Oliver S; Brindle L; Jewell D; Powell P; Gillatt D; Dedman D; Mills N; Smith M; Noble S; Lane A;
    Health Technol Assess; 2003; 7(14):1-88. PubMed ID: 12709289
    [No Abstract]   [Full Text] [Related]  

  • 50. Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach.
    Etzioni R; Gulati R; Falcon S; Penson DF
    Med Decis Making; 2008; 28(3):323-31. PubMed ID: 18319508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostate priorities: a new approach to the cancer that 1 in 6 American men will eventually get.
    Gupta S
    Time; 2004 Oct; 164(14):90. PubMed ID: 15503786
    [No Abstract]   [Full Text] [Related]  

  • 52. [Prostatic cancer in the Grand Duchy of Luxembourg. Role of PSA].
    Lamy S; Hein T; Wilmart JF; Capesius C; Scheiden R; Gilson G; Humbel RL
    Bull Soc Sci Med Grand Duche Luxemb; 1998; 135(1):11-23. PubMed ID: 9868829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostate-cancer screening.
    Catalona WJ
    N Engl J Med; 2009 Jul; 361(2):202; author reply 204-5. PubMed ID: 19587348
    [No Abstract]   [Full Text] [Related]  

  • 54. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
    Welch HG; Schwartz LM; Woloshin S
    J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quebec prostate cancer mortality dropped in 1996.
    Meyer F; Moore L; Bairati I; Fradet Y
    Cancer Prev Control; 1998 Aug; 2(4):163-6. PubMed ID: 10093628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Epidemiology of prostate cancer in the Limousin area].
    Druet-Cabanac M; Colombeau P; Preux PM; Paulhac P; Vergnenegre A; Dumas JP
    Prog Urol; 2002 Apr; 12(2):226-31. PubMed ID: 12108336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An iatrogenic confounding variable.
    Albertsen PC
    J Natl Cancer Inst; 2009 Oct; 101(20):1368-9. PubMed ID: 19741210
    [No Abstract]   [Full Text] [Related]  

  • 58. No one dies from prostate cancer?
    Chau D
    Arch Intern Med; 2006 Jul; 166(14):1525; author reply 1526. PubMed ID: 16864764
    [No Abstract]   [Full Text] [Related]  

  • 59. [Prostate cancer incidence, mortality, and survival rates in Japan].
    Kinoshita H; Ogawa O
    Nihon Rinsho; 2001 Nov; 59 Suppl 7():364-72. PubMed ID: 11808142
    [No Abstract]   [Full Text] [Related]  

  • 60. Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.
    Hu JC; Nguyen P; Mao J; Halpern J; Shoag J; Wright JD; Sedrakyan A
    JAMA Oncol; 2017 May; 3(5):705-707. PubMed ID: 28033446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.